CV Sciences Acquires Extract Labs

The Cannabist Company Acquires Ciencia Labs Portfolio

December 11, 2024

Retail

The Cannabist Company (formerly Columbia Care) acquired the Ciencia Labs portfolio earlier in 2024 and is launching the Ciencia Labs brand dreamt in Maryland, with additional markets and products planned for 2025. The acquisition expands The Cannabist Company’s branded product offerings and supports broader retail and wholesale distribution across its dispensary and wholesale channels.

CV Sciences Acquires Elevated Softgels

May 13, 2024

Manufacturing

CV Sciences, Inc. has completed an equity purchase of Elevated Softgels, LLC, a GMP-certified manufacturer of encapsulated softgels and tinctures, which will operate as a wholly owned subsidiary. The acquisition (up to $1.0M consideration) is intended to in-source production for CV Sciences' +PlusCBD products, increase sales to current and new clients, and leverage Elevated Softgels' low-MOQ and flexible production capabilities to drive cost savings and growth.

SC Labs Acquires C4 Laboratories

April 24, 2023

Healthcare Services

SC Labs, a leading U.S. cannabis and hemp testing company headquartered in Santa Cruz, California, has acquired C4 Laboratories of Scottsdale, Arizona. The acquisition expands SC Labs' licensed and accredited footprint to five states and adds C4's advanced cannabis testing capabilities to SC Labs' national testing and compliance platform.

Cannabinoid Biosciences Acquires CannabidiolHemp

November 25, 2019

Consumer Products

Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.

CURE Pharmaceutical to Acquire Sera Labs for $20 Million

July 30, 2020

Consumer Products

CURE Pharmaceutical entered a memorandum of understanding to acquire 100% of privately held Sera Labs for $20 million in a deal composed primarily of CURE stock, with potential earn-outs of up to an additional $20 million. The acquisition adds Sera Labs' CBD-focused branded portfolio, DTC subscription model and retail/wholesale distribution (over 8,850 U.S. doors) to CURE's cGMP manufacturing and drug-delivery capabilities, with Sera Labs founder Nancy Duitch remaining in a leadership role.

Charles River Laboratories Acquires Explora BioLabs

April 6, 2022

Biotechnology

Charles River Laboratories has acquired Explora BioLabs Holdings, a San Diego–based provider of contract vivarium services, for approximately $295 million in cash. The deal expands Charles River’s CRADL footprint with more than 15 additional vivarium facilities (bringing expected combined capacity to at least 25 sites and ~300,000 sq ft by end of 2022) and adds complementary preclinical vivarium management capabilities and clients.